INTERNATIONAL CELL SURGICAL SOCIETY (EIN 461473917) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

ELLIOT LANDER MD

Phone

7604640181

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL CELL SURGICAL SOCIETY, founded in 2013, is a small nonprofit in the Medical Research sector that reported $319K in total revenue in fiscal year 2024.

Mission

TO PROMOTE THE USE OF PROGENITOR/STEM CELLS AND OTHER CELLULAR THERAPIES IN THE TREATMENT OF DISEASE, TRAUMATIC INJURY AND CHRONIC PAIN; TO PROVIDE EDUCATION RELATED TO THIS TYPE OF MEDICAL TREATMENT AND THERAPIES; TO MAINTAIN AND PROMOTE LABORATORY PRACTICE AND CLINCIAL GUIDELINES RELATED TO THIS TYPE OF MEDICAL TREATMENT AND THERAPIES; AND TO DESIGN AND MANAGE AN ACCREDITATION PROGRAM TO EVALUATE CLINICS AND FACILITIES THAT PROVIDE THESE TYPES OF MEDICAL TREATMENTS AND THERAPIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $319,420

Investment Income $0

Other Revenue $0

TOTAL REVENUE $319,420

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $309,174

Other Expenses $316,719

TOTAL EXPENSES $316,719

Year-over-Year Comparison

	2024	2023	Change
Revenue	$319,420	$301,083	+0.1%
Expenses	$316,719	$318,832	0.0%
Net Income	$2,701	$-17,749	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELLIOT LANDER MD	PRESIDENT	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$319,420	$316,719	$261,692	$2,701
2023	$301,083	$318,832	$268,992	$-17,749
2022	$223,950	$323,180	$286,741	$-99,230
2021	$309,552	$295,420	$386,871	$14,132
2020	$152,320	$173,694	$29,653	$-21,374
2019	$278,066	$322,446	$34,825	$-44,380
2018	$99,146	$140,374	$29,796	$-41,228

INTERNATIONAL CELL SURGICAL SOCIETY